Furthermore, the inhibition of USP10 mediates the deubiquitination of YBX1, resulting in a decrease in the expression levels of YBX1, promoting pan apoptosis in GC cells and reducing oxaliplatin resistance (137). The gene discussed is YBX1; the disease is gastric cancer.